Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Economic evaluation of pharmaceuticals: a European perspective.

M Drummond1, F Rutten, A Brenna

  • 1Centre for Health Economics, University of York, England.

Pharmacoeconomics
|August 6, 1993
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pathological features of Xp11 translocation renal cell carcinoma using urine liquid-based cytology with FISH.

Cytopathology : official journal of the British Society for Clinical Cytology·2014
Same author

Frequency and clinical significance of human beta-herpesviruses in cervical samples from Italian women.

Journal of medical virology·2007
Same author

Evolution of the in-patient hospital expenditure for the elderly in Italy: 1996-2001 comparison.

Archives of gerontology and geriatrics·2006
Same author

Current trends in the use of pharmacoeconomics and outcomes research in europe.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research·2006
Same author

Change in stem cell source for hematopoietic stem cell transplantation (HSCT) in Europe: a report of the EBMT activity survey 2003.

Bone marrow transplantation·2005
Same author

Clear cell carcinoma of minor salivary gland of the tongue.

Acta otorhinolaryngologica Italica : organo ufficiale della Societa italiana di otorinolaringologia e chirurgia cervico-facciale·2004

Economic evaluations of pharmaceuticals are increasing, but Europe lacks clear guidelines. This hinders pharmaceutical companies and analysts in developing effective strategies for study methodology and implementation.

Area of Science:

  • Health Economics
  • Pharmaceutical Policy

Background:

  • Growing number of pharmaceutical economic evaluations commissioned by companies.
  • Australia and Canada have issued draft guidelines for reimbursement submissions.
  • Europe presents a diverse landscape of healthcare systems and pricing/reimbursement approaches.

Purpose of the Study:

  • Review official guidance for economic evaluations in Europe.
  • Assess the potential uses and impact of these evaluations.
  • Inform pharmaceutical companies on strategy and analysts on methodology.

Main Methods:

  • Review of existing literature and country-specific policies.
  • Analysis of the nature, conduct, and impact of economic evaluations in Europe.
  • Classification of potential uses for economic evaluations.

Related Experiment Videos

Main Results:

  • No official European guidance currently exists, though some countries are considering it.
  • Potential uses vary, including price negotiations, reimbursement decisions, and formulary inclusion.
  • Approximately 80 evaluations conducted in Europe with limited identifiable impact to date.

Conclusions:

  • Economic evaluation of medicines is expected to gain relevance in Europe.
  • Pharmaceutical companies face challenges in determining optimal timing and methods for evaluations.
  • The lack of clear guidelines necessitates strategic planning for industry stakeholders.